Validity and usefulness of the short form of the Drinking Motives Questionnaire Revised (DMQ-R SF) among patients with schizophrenia.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
06 2022
Historique:
received: 17 08 2021
revised: 21 12 2021
accepted: 14 01 2022
pubmed: 31 1 2022
medline: 22 3 2022
entrez: 30 1 2022
Statut: ppublish

Résumé

Drinking motives are considered to be major predictors of alcohol consumption and alcohol-related problems. However, these motives have been poorly investigated in patients with schizophrenia. The aim of the present study among patients with schizophrenia was twofold: 1) assess the validity of the short form of the Drinking Motives Questionnaire-Revised (DMQ-R SF); and 2) investigate the relationship between drinking motives and comorbid alcohol use disorder (AUD). A total of 179 patients with schizophrenia were approached to participate in the study. DSM-5 criteria were used to identify patients with comorbid AUD (AUD+; n = 42) and non-abstainers patients without comorbid AUD (AUD-; n = 71). A confirmatory factor analysis conducted on items of the DMQ-R SF for the whole sample revealed adequate goodness-of-fit values, while internal consistency indices were globally satisfactory. Group comparisons revealed higher use of alcohol and other substances, as well as stronger drinking motives among AUD + patients, while groups were comparable concerning clinical features of schizophrenia, including psychotic symptom dimensions and severity. Regression analysis showed that the Alcohol Use Disorder Identification Test score was significantly associated with two internal drinking motives: enhancement and coping. Findings suggest that the DMQ-R SF is a reliable tool for assessing drinking motives among patients with schizophrenia. Enhancement and coping motives seem to play a major role in comorbid AUD among these patients. Community-based and clinical treatment programs should take the drinking motives of dual-diagnosis patients into consideration, in order to improve their outcomes.

Identifiants

pubmed: 35093808
pii: S0306-4603(22)00017-X
doi: 10.1016/j.addbeh.2022.107251
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107251

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Fabien Gierski (F)

Cognition Health Society Laboratory (C2S - EA 6291), University of Reims Champagne Ardenne, Reims, France; Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, Reims, France; Research Group on Alcohol and Dependences, INSERM & University of Picardy Jules Verne, Amiens, France; Department of Psychiatry and Addiction, Amiens University Hospital, Amiens, France; Institute of Psychiatry and Addictions, Paris, France. Electronic address: fabien.gierski@univ-reims.fr.

Farid Benzerouk (F)

Cognition Health Society Laboratory (C2S - EA 6291), University of Reims Champagne Ardenne, Reims, France; Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, Reims, France; Institute of Psychiatry and Addictions, Paris, France.

Jérôme Jeanblanc (J)

Research Group on Alcohol and Dependences, INSERM & University of Picardy Jules Verne, Amiens, France; Institute of Psychiatry and Addictions, Paris, France.

Bernard Angerville (B)

Research Group on Alcohol and Dependences, INSERM & University of Picardy Jules Verne, Amiens, France; Department of Psychiatry and Addiction, Amiens University Hospital, Amiens, France; Institute of Psychiatry and Addictions, Paris, France.

Alain Dervaux (A)

Research Group on Alcohol and Dependences, INSERM & University of Picardy Jules Verne, Amiens, France; Department of Psychiatry and Addiction, Amiens University Hospital, Amiens, France; Institute of Psychiatry and Addictions, Paris, France.

Arthur Kaladjian (A)

Cognition Health Society Laboratory (C2S - EA 6291), University of Reims Champagne Ardenne, Reims, France; Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, Reims, France; Institute of Psychiatry and Addictions, Paris, France.

Mickaël Naassila (M)

Research Group on Alcohol and Dependences, INSERM & University of Picardy Jules Verne, Amiens, France; Institute of Psychiatry and Addictions, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH